Atai Life Sciences Gross Margin 2020-2025 | ATAI

Current and historical gross margin for Atai Life Sciences (ATAI) over the last 10 years. The current gross profit margin for Atai Life Sciences as of March 31, 2025 is %.
Atai Life Sciences Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.00B $0.00B 100.00%
2024-09-30 $0.00B 0 0.00%
2024-06-30 $0.00B 0 0.00%
2023-12-31 $0.00B 0 0.00%
2023-09-30 $0.00B 0 0.00%
2023-06-30 $0.00B 0 0.00%
2023-03-31 $0.00B 0 0.00%
2022-09-30 $0.00B 0 0.00%
2022-06-30 $0.00B 0 0.00%
2021-12-31 $0.02B $0.02B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.715B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.848B 18.01
DaVita (DVA) United States $10.960B 15.41
Encompass Health (EHC) United States $10.853B 23.01
Elanco Animal Health (ELAN) United States $7.410B 15.87
Chemed (CHE) United States $6.886B 21.64
Option Care Health (OPCH) United States $4.862B 21.67
RadNet (RDNT) United States $4.307B 273.38
Amedisys (AMED) United States $3.214B 21.62
Addus HomeCare (ADUS) United States $2.013B 22.11
LifeStance Health (LFST) United States $1.610B 0.00
Astrana Health (ASTH) United States $1.305B 32.32
U.S Physical Therapy (USPH) United States $1.128B 29.12
Pennant (PNTG) United States $0.805B 29.56
Aveanna Healthcare Holdings (AVAH) United States $0.773B 44.00
Daxor (DXR) United States $0.049B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.037B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00